Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 259-910-3 | CAS number: 55934-93-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1989
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP study according to OECD guideline 474
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 989
- Report date:
- 1989
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- [(butoxymethylethoxy)methylethoxy]propan-1-ol
- EC Number:
- 259-910-3
- EC Name:
- [(butoxymethylethoxy)methylethoxy]propan-1-ol
- Cas Number:
- 55934-93-5
- Molecular formula:
- C13H28O4
- IUPAC Name:
- 1-[2-(2-butoxy-1-methylethoxy)-1-methylethoxy]propan-1-ol
- Details on test material:
- - Name of test material (as cited in study report): Tripropylene glycole-n-butyl ether
- Molecular formula (if other than submission substance): C13H28O4
- Molecular weight (if other than submission substance): 248
- Physical state: liquid
- Analytical purity:96.12%
- Impurities (identity and concentrations):
- Lot/batch No.: EB880621R004
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- CD-1
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: charles River, Kingston,NY
- Age at study initiation: 8 week old
- Assigned to test groups randomly: yes
- Housing:singly
- Diet - ad libitum)
- Water - ad libitum)
- Acclimation period:one week
ENVIRONMENTAL CONDITIONS
adequate environmental condition
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: corn oil
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: single oral dose
DIET PREPARATION
- Rate of preparation of diet (frequency):
- Mixing appropriate amounts with (Type of food):
- Storage temperature of food: - Frequency of treatment:
- single
- Post exposure period:
- groups of animals were sacrificed at 3 intervals 24, 48, and 72h after treatment.
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 187.5, 625.0, and 1875.0 mg/kg bw
Basis:
- No. of animals per sex per dose:
- 5 animals per sex per dose per treatment time
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- cyclophosphamide
- Justification for choice of positive control(s): historical data
- Route of administration: oral
- Doses / concentrations:120mg/kg body weight
Examinations
- Tissues and cell types examined:
- bone marrow cells for PCE
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: based on the dose range finding test
TREATMENT AND SAMPLING TIMES: at 24, 48, 72h
DETAILS OF SLIDE PREPARATION: At the end of the sacrificed intervals following dosing, the animals were sacrificed by cervical dislocation. Bone morrow samples were obtained from the femurs. Bone marrow was aspirated into fetal bovine serum. After aspiration, the contents of the syringe were transferred into a 1.5 ml centrifuge tube containing 0.5 ml of serum. The cells were resuspended in serum by gentle aspiration using the syringe and needle to centrifuge. After centrifugation supernatant was discarded leaving a small amount of serum covering the pellet. The cell pellet was resuspended using a disposable transfer pipet. Cell smear were prepared on microscope slides using small portions of the cell suspension. The cells were allowed to air dry, fixed in methanol and stained in 5% Giemsa.
METHOD OF ANALYSIS: The slides were coded and scored blindly. One thousand PCE were examined from each animal and the number of micronucleated polychromatic erythrocytes (MN-PCE) was recorded. Micronuclei were identified as darkly stained bodies with sharp contours and varying shapes such as round, almond or ring (Schmid, 1976). The ratio of PCE-NCE in the bone marrow was determined by examining 1000 erythrocytes. The ratio was expressed as PCEx100/PCE+NCE. - Evaluation criteria:
- There are several criteria for determining a positive result, such as a dose-related increase in the number of micronucleated cells or a clear increase in the number of micronucleated cells in a single dose group at a single sampling time. Biological relevance of the results should be considered first. Statistical methods may be used as an aid in evaluating the test results.
Statistical significance should not be the only determining factor for a positive response. Equivocal results should be clarified by further testing preferably using a modification of experimental conditions.
A test substance for which the results do not meet the above criteria is considered nonmutagenic
in this test.
Although most experiments will give clearly positive or negative results, in rare cases the data set will preclude making a definite judgement about the activity of the test substance. Results, may remain equivocal or questionable regardless of the number of times the experiment is repeated.
Positive results in the micronucleus test indicate that a substance induces micronuclei which are the result of chromosomal damage or damage to the mitotic apparatus in the erythroblasts of the test species. Negative results indicate that, under the test conditions, the test substance does not produce micronuclei in the immature erythrocytes of the test species.
The likelihood that the test substance or its metabolites reach the general circulation or specifically the target tissue (e.g. systemic toxicity) should be discussed.
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results: negative
There were no significant increases in the frequencies of MN-PCE in groups treated with DOWANOL TPnB compared to negative controls. The positive control mice showed significant increases in MN-PCE. Hence, under the experimental conditions used, DOWANOL TPnB was considered negative in the mouse bone marrow micronucleus test. - Executive summary:
DOWANOL TPnB was evaluated in the mouse bone marrow micronucleus test. The micronucleus test is capable of
detecting agents causing chromosomal aberrations and spindle malfunction. DOWANOL TPnB was mixed with corn oil and administered to CD-1(ICR) BR mice by single oral gavage at dose levels of 0 (negative control), 187.5, 625.0, and 1875.0 mg/kg body weight.
Groups of animals were sacrificed at three intervals, viz., 24, 48, and 72 hours after treatment. Mice treated with 120mg/kg body weight cyclophosphamide and sacrificed at 24 hour served as positive controls. There were five animals
per sex per dose level per sacrifice time. At the end of the sacrificed intervals following dosing, the animals were sacrificed by cervical dislocation. Bone morrow samples were obtained from the femurs. Bone marrow was aspirated into fetal bovine serum. After aspiration, the contents of the syringe were transferred into a 1.5 ml centrifuge tube containing 0.5 ml of serum. The cells were resuspended in serum by gentle aspiration using the syringe and needle to centrifuge. After centrifugation supernatant was discarded leaving a small amount of serum covering the pellet. The cell pellet was resuspended using a disposable transfer pipet. Cell smear were prepared on microscope slides using small portions of the cell suspension. The cells were allowed to air dry, fixed in methanol and stained in 5% Giemsa.The slides were coded and scored blindly. One thousand PCE were examined from each animal and the number of micronucleated polychromatic erythrocytes (MN-PCE) was recorded. Micronuclei were identified as darkly stained bodies with sharp contours and varying shapes such as round, almond or ring (Schmid, 1976). The ratio of PCE-NCE in the bone marrow was determined by examining 1000 erythrocytes. The ratio was expressed as PCEx100/PCE+NCE.
Based on study results there were no significant increases in the frequencies of MN-PCE in groups treated with DOWANOL TPnB compared to negative controls. The positive control mice showed significant increases in MN-PCE. Hence, under experimental conditions used, DOWANOL TPnB was considered negative in the mouse bone marrow micronucleus test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.